Mr. Chair, was it not just recently announced, I think maybe even at the G7, that we're going to be also providing additional funding towards the COVAX facility? This is where.... I think within this committee you've heard me talk quite a bit about international patents, TRIPS waivers, our hoarding of the [Technical difficulty—Editor] with the highest portfolio. Are we taking from COVAX? Are we actually giving doses to COVAX or are we still taking doses from the COVAX facility even as we seem to be touting being in a surplus position of vaccine procurement?
On June 16th, 2021. See this statement in context.